Daiichi Sankyo
Quizartinib Poised to Change Treatment Paradigm for AML
Adding quizartinib (Daiichi Sankyo) to standard chemotherapy and consolidation significantly improves overall ...
JULY 13, 2022
FDA Approves Turalio for TGCT, a Rare Joint Tumor
The FDA approved Turalio, Daiichi Sankyo to treat adults with symptomatic tenosynovial giant cell tumor (TGCT) ...
AUGUST 8, 2019
Load more